PETTI, Maria Concetta
 Distribuzione geografica
Continente #
NA - Nord America 354
EU - Europa 80
AS - Asia 51
SA - Sud America 3
OC - Oceania 1
Totale 489
Nazione #
US - Stati Uniti d'America 352
SE - Svezia 25
IN - India 18
IT - Italia 18
SG - Singapore 17
CN - Cina 12
FI - Finlandia 7
UA - Ucraina 7
BG - Bulgaria 6
DE - Germania 5
BE - Belgio 4
RO - Romania 4
AR - Argentina 3
CA - Canada 2
IE - Irlanda 2
TR - Turchia 2
AU - Australia 1
EE - Estonia 1
GB - Regno Unito 1
HK - Hong Kong 1
IR - Iran 1
Totale 489
Città #
Fairfield 52
Chandler 36
Ann Arbor 27
Cambridge 23
Woodbridge 22
Ashburn 20
Houston 20
Wilmington 19
Seattle 16
Princeton 15
Florence 10
Des Moines 9
Plano 9
Boston 7
San Diego 7
Singapore 7
Beijing 6
Sofia 6
Brussels 4
Lawrence 4
San Paolo di Civitate 4
Andover 3
Federal 3
Dublin 2
Istanbul 2
Jinan 2
Millbury 2
Naples 2
Ottawa 2
Rome 2
Boardman 1
Bremen 1
Bühl 1
Dearborn 1
Frankfurt am Main 1
Fuzhou 1
Hefei 1
Jacksonville 1
Kashan 1
Kunming 1
London 1
Nanjing 1
Olinda 1
Phoenix 1
San Jose 1
San Mateo 1
Tallinn 1
Trumbull 1
Totale 361
Nome #
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients 88
Late relapses in acute promyelocytic leukaemia 65
Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10 57
null 55
Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene. 49
Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization 48
Idarubicin in acute leukaemia. GIMEMA Group. 36
Mitoxantrone, Etoposide and Intermediate-dose Ara-c (mec) - An Effective Regimen For Poor Risk Acute Myeloid-leukemia 33
GIMEMA ALL 0183: Multicentric study on adult acute lymphoblastic leukemia. The 1990 update. 27
Second ANLL (M2) with t(8;21) following Ph1 + ALL 26
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients 20
Totale 504
Categoria #
all - tutte 1.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020113 15 3 2 5 13 13 16 16 12 5 9 4
2020/202132 2 4 1 4 1 0 4 3 2 9 1 1
2021/2022111 5 8 8 7 15 6 0 9 8 7 20 18
2022/2023134 27 13 4 11 15 25 4 7 23 1 2 2
2023/202444 4 9 0 6 4 7 2 0 0 5 3 4
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 504